EasySep™小鼠TIL（CD45）正选试剂盒
Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors.
Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors.
很抱歉, 生成此内容时发生错误。
沪公网安备31010102008431号